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Abstract 
Background 
Findings from epidemiological studies regarding seasonal variations in the association 
between vitamin D status and depression are inconsistent. 
Methods 
Cross-sectional analysis of data from 6,331 participants aged 18-79 years in the nationwide 
representative German Health Interview and Examination Survey for Adults 2008-2011 
(DEGS1). Associations between 25-hydroxy-vitamin-D (25(OH)D) serum levels in quartiles 
and current depressive symptoms as measured by the Patient Health Questionnaire depression 
module (PHQ-9) and defined as severity of depressive symptoms (PHQ-9 score, range 0-27 
points) and elevated depressive symptoms (PHQ-9 score >= 10 points) were analysed using 
multivariable linear and logistic regression adjusted for sociodemographic, biological and 
lifestyle factors. Analyses were stratified by summertime (May to October) and wintertime 
(November to April) because of evidence for interaction with season (p=<0.01). 
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Results 
In crude analyses, vitamin D status was inversely associated with both depression outcomes in 
summertime but not in wintertime. After adjustment for potential confounders, a significant 
association with severity of depressive symptoms remained in summer, with 0.73 point lower 
PHQ-9 scores in the highest versus lowest quartile. The association between 25(OH)D 
quartiles and elevated depressive symptoms in summertime was less strong and no longer 
significant in fully adjusted models. 
 
Limitations 
Participants with severe depression may be underrepresented in DEGS1. Residual 
confounding cannot be excluded. 
 
Conclusion 
25(OH)D serum levels were inversely associated with current depressive symptoms in 
summer but not in wintertime. The fact that the association is stronger in summertime 
suggests that vitamin D deficiency may be a consequence rather than a cause of depression. 
 
 
1. Introduction 
Depression is a highly prevalent mental disorder and an important public health issue 
worldwide. It is one of the leading contributors to the global burden of disease, a major cause 
of disability (Ferrari et al., 2013) and associated with increased mortality and high healthcare 
costs (Cuijpers and Smit, 2002; Sobocki et al., 2006; Zheng et al., 1997).  
4 
 
The etiology of depression is not completely established. Besides psychosocial factors, 
different biological and environmental factors are considered to play a potential role in its 
pathophysiology (Saveanu and Nemeroff, 2012). Increasingly, vitamin D deficiency is being 
suggested as a contributor to depression (Ju et al., 2013; Milaneschi et al., 2014). The 
presence of vitamin D receptors and vitamin D-activating enzymes in several parts of the 
human brain known to contribute to the regulation of mood like the hippocampus, 
hypothalamus and prefrontal cortex provide plausible biological explanations for the 
relationship between vitamin D deficiency and low mood (Eyles et al., 2005). In addition, 
there is evidence that vitamin D is a potent inducer of nerve growth factor synthesis (Brown et 
al., 2003; Wion et al., 1991) and is involved in the expression of monoamines, such as 
norepinephrine and serotonin, which are associated with depression (Cass et al., 2006; 
Garcion et al., 2002; Smith et al., 2006). 
Depressive symptoms are common during winter among countries in northern latitudes when 
vitamin D levels may be lower due to inadequate ultraviolet B (UVB) radiation resulting in 
decreased vitamin D synthesis in the skin (Engelsen et al., 2005; Tsiaras and Weinstock, 
2011). Remarkably, relatively few studies have examined the influence of season on the 
association between vitamin D and depression (Brandenbarg et al., 2012; Hoang et al., 2011; 
Kjaergaard et al., 2011; Nanri et al., 2009; Stewart and Hirani, 2010). Results from these 
studies were mixed; three studies did not observe an influence of season (Brandenbarg et al., 
2012; Nanri et al., 2009; Stewart and Hirani, 2010), while the other two studies reported 
conflicting evidence for an inverse association between vitamin D and depressive symptoms 
in winter (Hoang et al., 2011) and in summer (Kjaergaard et al., 2011).  
In this study, we examined the association between 25(OH)D serum levels and current 
depressive symptoms by season in a nationally representative sample of adults in Germany; a 
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northern European country with well-defined seasons and a latitudinal position between 47°-
55°N where vitamin D skin sythesis is limited between October and March (Rabenberg et al., 
2015) . 
 
2. Methods 
2.1 Study design and subjects  
The ‘German Health Interview and Examination Survey for Adults’ (DEGS1) was conducted 
between November 2008 and December 2011 and included a nationwide representative 
population-based sample of adults aged 18–79 years in Germany. The design and methods of 
DEGS1 have been described in detail elsewhere (Kamtsiuris et al., 2013; Rabenberg et al., 
2015; Scheidt-Nave et al., 2012). Briefly, participants were selected using a two-stage 
stratified random sampling procedure from local population registries at 180 selected sample 
points across Germany. The sequence of places visited by two mobile study teams was laid 
down in advance in a random touring schedule, in order to avoid a systematic bias of study 
results by seasonal or time trends or municipality size (Gosswald et al., 2013).  
In total, 7,987 persons aged 18-79 years took part in DEGS1 and of these, 7,115 participants 
had a wide range of examinations and blood tests in addition to a physician-administered 
personal interview and a self-administered questionnaire.  
For this study, participants with missing data on serum levels of 25-hydroxy-vitamin-D 
(25(OH)D) (n=120), depressive symptoms (n=369) or relevant covariables (n=295) were 
excluded, resulting in a study population of 6,331 persons (3,290 women; 3,041 men).  
DEGS1 was developed in line with the principles of the Declaration of Helsinki and was 
approved by the Federal and State Commissioners for Data Protection and by the ethics 
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committee of the Charité-Universitätsmedizin Berlin (No. EA2/047/08). Written informed 
consent was obtained from participants. 
 
2.2 Data collection and measures 
2.2.1 Depressive symptoms 
Presence and frequency of depressive symptoms in the two weeks prior to interview was 
assessed with the German version of the 9-item depression module of the Patient Health 
Questionnaire (PHQ-9) (Busch et al., 2013; Kroenke et al., 2001). The items of this written, 
self-administered questionnaire are based on the nine diagnostic criteria for major depression 
of the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) including 
depressed mood, decreased interest or pleasure in activities, significant weight change or 
change in appetite, insomnia or hypersomnia, psychomotor agitation or retardation, fatigue or 
loss of energy, feelings of worthlessness or guilt, problems with concentration, and suicidal 
thoughts (American Psychiatric Association, 2013). The frequency of each diagnostic 
criterion is rated as 0 (“not at all”), 1 (“several days”), 2 (“more than half the days”) or 3 
(“nearly every day”). Individual item scores are summed to produce a PHQ-9 total score, 
ranging from 0 to 27. Persons with scores of  >=10 are categorized as having elevated 
depressive symptoms (Kroenke et al., 2001). 
In the present study, the PHQ-9 score was analysed as both a continuous variable (range 0-27) 
for severity of depressive symptoms and as a dichotomous variable using the cut-point case 
definition (PHQ-9 score >=10) for elevated depressive symptoms. 
 
2.2.2 Vitamin D status 
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Venous blood samples were drawn at study assessement centres and immediately centrifuged 
and separated. Serum samples were aliquoted and stored at −40°C. Samples were transported 
and analysed at the central epidemiology laboratory unit at the Robert Koch Institute, Berlin. 
Measurement of serum 25(OH)D was carried out using a Liaison chemiluminescence 
immunoassay (DiaSorin Inc., Stillwater, MN, USA). Full details on analyses have been 
described elsewhere (Rabenberg et al., 2015). When measured serum 25(OH)D values were 
below 10 nmol/l, the lower detection level of the assay, values were set to 9 nmol/l. This was 
the case for 111 participants. For all analyses, serum 25(OH)D quartiles were used. 
 
2.2.3 Covariables 
Socio-demographic, biological and lifestyle factors which are known to be associated with 
depressive symptoms and vitamin D status were taken into account as potential confounders. 
Extended season was defined by the month of examination and categorised as summertime 
(May-October) in which UVB exposure is more likely to be adequate for vitamin D skin 
synthesis and wintertime (November-April) (Rabenberg et al., 2015).  
Socio-economic status (SES) was defined using information on education, occupation, and 
household income and was categorized as low, middle and high (Lampert et al., 2013). Living 
arrangements and marital status were assessed by a self-administered questionnaire and 
dichotomized into living in a partnership (including married persons) versus not living in a 
partnership (separated, divorced, widowed or single). Municipality size was classified as rural 
(<5,000 inhabitants), small town (5,000 to <20,000 inhabitants), medium-sized town (20,000 
to <100,000 inhabitants) and large town (≥100,000 inhabitants) (Kamtsiuris et al., 2013). 
As skin pigmentation and cultural dress codes (e.g. veiling) are known to influence vitamin D 
skin synthesis (Palacios and Gonzalez, 2014), we attempted to consider these factors using 
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country of birth of participants in the analysis. Drawing on a previous study investigating 
vitamin D deficiency and immigration background in Germany (Hintzpeter et al., 2008), we 
grouped country of birth into ‘Germany’, ‘Europe and Western countries’ (including USA, 
Canada, Europe and the former Soviet Union), ‘Arab-Islamic countries’ (including Turkey, 
the largest immigrant group in Germany) and ‘remaining countries’ (including Latin America, 
Asia and Africa). 
Body weight and height were measured with standardized measurements with participants 
wearing underwear only. Body Mass Index (BMI) was calculated as weight (in kg)/(height (in 
m))
2 
and categorized as obese (BMI >=30) or non-obese (BMI <30) according to World 
Health Organization recommendations (World Health Organization, 2000). Physical function 
was assessed by the 10-item physical functioning (PF) subscale of the Short Form-36 Health 
Survey (SF-36) (Jenkinson et al., 1999; Ware, 2000). Established methods were used to 
calculate PF scores ranging from 0 to 100, with higher scores indicating better physical 
functioning (Ware et al., 2007). Kidney function was assessed by the estimated glomerular 
filtration rate (eGFR) based on serum creatinine level and using the equation from ‘The 
Chronic Kidney Disease Epidemiology Collaboration’ (CKD-EPI) (Levey et al., 2009): eGFR 
= 141 x min(SCr /κ, 1)
α
 x max(SCr /κ, 1)
-1.209
 x 0.993
Age
 x 1.018 [if female]. SCr stands for 
standardized serum creatinine in mg/dL, k is 0.7 for females and 0.9 for males, α is -0.329 for 
females and -0.411 for males, min indicates the minimum of SCr /κ or 1, and max indicates the 
maximum of SCr /κ or 1. An eGFR value of 90 mL/min/1.73 m
2
 or higher designates a normal 
level in most healthy people. 
Smoking status was classified as current smoking (even occasionally) or no current smoking 
(including former and never smoking). Volume and frequency of alcohol consumption was 
grouped into the categories ‘no consumption’, ‘alcohol consumption with <10 g/day for 
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women and <20 g/day for men’ and ‘alcohol consumption with >=10 g/day for women and 
>=20 g/day for men’ according to tolerable maximum intake per day from the German 
Nutrition Society (Deutsche Gesellschaft für Ernährung e.V. et al., 2015). Sports activity in 
the last three months was assessed by the question ‘How often do you participate in sports 
during one week?’(Krug et al., 2013). The response options ‘I don’t do any sports’, ‘less than 
1 hour’, ‘regularly 1 to 2 hours’, ‘regularly 2 to 4 hours’ and ‘regularly more than 4 hours’  
were dichotomized into ‘no sport activity/week’ and ‘sport activity >0 hour/week’.  
 
2.3 Statistical Analyses 
Prevalences and means of sample characteristics were calculated according to 25(OH)D 
quartiles and elevated depressive symptoms (PHQ-9 >= 10). Associations between sample 
characteristics and 25(OH)D quartiles and elevated depressive symptoms were tested using 
the chi-square test for categorical variables and linear regression for continuous variables.  
In preliminary analyses, we tested for interaction between 25(OH)D quartiles and sex, age 
group and extended season by adding multiplicative interaction terms to linear and logistic 
regression models that included these variables (data not shown). While there was no 
evidence for an interaction with age group or sex, an interaction with extended season was 
seen for both depressive symptoms variables (p=<0.01). Thus, all analyses were stratified by 
summertime and wintertime.  
To examine associations between 25(OH)D quartiles and depressive symptoms, we first 
calculated mean PHQ-9 scores and prevalences of elevated depressive symptoms year-round 
and then stratified these by summer and wintertime. We initially tested for trends across 
serum 25(OH)D quartiles using unadjusted linear and logistic regression analyses.  
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We then performed multivariable analyses stratified by summer and wintertime. We used 
multivariable linear regression when severity of depressive symtoms (PHQ-9 score) was the 
dependent variable and logistic regression when elevated depressive symptoms (PHQ-9 >=10) 
was the dependent variable. Multivariable regression models were adjusted for: sex, age, SES, 
living arrangements (living in a partnership), municipality size, country of birth, obesity, 
physical functioning, kidney function (eGFR), smoking status, alcohol consumption and 
sports activity. 
All analyses were calculated using a weighting factor which accounts for the sampling design 
and corrects sample deviations from the German population structure (as on 31. December 
2010) with regard to age group, sex, region, nationality, type of municipality and education. 
To take into account both the weighting factor and the correlation of participants within 
communities, all analyses were performed with complex samples procedures in SPSS version 
20.0 (SPSS Inc.,Chicago, Illinois, USA). For all analyses, a p-value <0.05 based on two-sided 
tests was considered statistically significant. 
 
3. Results 
The mean age of the sample was 46.8 (95% CI 46.3-47.3) years and mean value of serum 
25(OH)D was 46.2 nmol/l (95% CI 44.1-48.3) with no significant differences between 
women and men (46.7 nmol/l vs. 45.7 nmol/l; p-value = 0.28). The mean value of PHQ-9 
score was 4.1 (95% CI 3.9-4.2) and 7.5 % had elevated depressive symptoms (PHQ-9 >=10). 
Table 1 summarizes the characteristics of the study population across serum 25(OH)D 
quartiles and for persons with and without elevated depressive symptoms.  Participants in the 
highest vitamin D quartile were more likely to be younger. For example, the proportion of 
participants in the age group 18 to 29 years increased from 19.8% in the lowest quartile to 
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24.3% in the highest quartile, with p<0.001 for difference in all age groups across quartiles. 
The proportion of participants examined in summertime rose from 19.1% in the lowest to 
72.9% in the highest quartile (p<0.001). Participants in the highest quartiles were also more 
likely to have higher SES, to live in a partnership, to live in large towns, to be of German 
origin, to not be obese, to have higher physical functioning, to drink less alcohol and to 
regularly participate in sport.  
Having elevated depressive symptoms was associated with being female, belonging to 
younger age groups, lower SES, not living in a partnership, living in larger towns, not being 
of German origin, obesity, lower physical functioning, current smoking and not participating 
in sports activities.  
Characteristics of participants, however, did not differ by half year (data not shown). 
Table 2 shows the severity of depressive symptoms (mean PHQ-9 score) and the prevalence 
of elevated depressive symptoms (PHQ-9 >=10) according to serum 25(OH)D quartiles year-
round and by summer and wintertime. Increasing vitamin D serum concentration was 
significantly associated with lower severity of depressive symptoms, year-round and in 
summertime, but not wintertime. In relation to elevated depressive symptoms, there was a 
significant association with vitamin D status only in summertime.  
Table 3 and 4 present the results of the multivariable regression analyses. There was a 
consistent significant association with mean PHQ-9 scores in summertime, but not 
wintertime, across all multivariable linear regression models (Table 3). In the fully adjusted 
linear model (Model 4), there was a 0.73 lower PHQ-9 score in the highest versus the lowest 
quartile. However, the association between serum 25(OH)D quartiles and the prevalence of 
elevated depressive symptoms (PHQ-9 >=10) in the logistic regression analyses was no 
longer significant after adjusting for biological factors and health behaviour (Table 4). In the 
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wintertime, there was no consistent association between vitamin D status and mean PHQ-9 
scores (Table 3) or elevated depressive symptoms (Table 4) . 
 
4. Discussion 
In this large nationwide representative study of the population aged 18–79 years in Germany, 
we found an inverse association between serum 25(OH)D levels and current depressive 
symptoms in summertime, but not wintertime.  
Our study examined two aspects of current depressive symptoms as outcomes; the severity of 
symptoms using a PHQ-9 as a continous variable and a cut-point based case definition of 
elevated depressive symptoms. Interestingly, we found significant associations persisted in 
the final linear regression model, but not in the logistic regression analysis using a case 
definition of depressive symptoms as the outcome. These differences highlight how different 
methodological approaches influence results and the need for specificity in reporting. 
Associations between depressive symptoms and vitamin D status in the linear models show 
that although the association is present in summertime, relationships between clinical 
thresholds for depressive symptoms and vitamin D status may be under greater influence of 
other biological and lifestyle factors than the season.  
In the last decade, several studies examined the association between vitamin D and depression 
(Ganji et al., 2010; Hoogendijk et al., 2008; Lee et al., 2011; Milaneschi et al., 2010; Polak et 
al., 2014; Williams et al., 2014). Findings have been inconsistent, with some studies reporting 
a relationship (Ganji et al., 2010; Hoogendijk et al., 2008; Lee et al., 2011; Milaneschi et al., 
2010; Polak et al., 2014; Williams et al., 2014) and others finding no relationship (Almeida et 
al., 2015; Pan et al., 2009; Zhao et al., 2010). Although depressive symptoms are common 
during winter times in northern latitudes, only a few studies specifically examined the 
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influence of season on the association (Brandenbarg et al., 2012; Hoang et al., 2011; 
Kjaergaard et al., 2011; Nanri et al., 2009; Stewart and Hirani, 2010).  
Our findings are consistent with results reported from the ‘Tromsø Study’ in Norway, a 
longitudinal, population-based study which measured vitamin D status and depressive 
symptoms (defined as a score >=1.85 on Hopkins Symptoms Check List 10 (SCL-10)) in 
10,086 persons aged 30 to 87 years (Kjaergaard et al., 2011). In this north Norwegian study, 
logistic regression analyses stratified by half year and smoking status showed that in the 
summertime serum 25(OH)D was a significant predictor of the SCL-10 score in females in 
the non-smoking group (p=0.020) and in males in the smoking group (p=0.035). Nevertheless, 
effect modification by season was not statistically tested. 
Contrary to our findings are those from a cross-sectional study of 12,594 people aged 20 to 90 
years attending a preventive medicine clinic in Texas, in the US. In this study, an inverse 
association between vitamin D levels and current depressive symptoms (defined as 10-item 
Center for Epidemiologic Studies Depression (CES-D) scale score of >=10) was observed for 
wintertime (October to March) (OR=0.87 (0.80-0.95); p=0.001) but not summertime (April to 
September) (OR= 0.96 (0.89-1.02); p=0.2) (Hoang et al., 2011). However, interaction testing 
between season and vitamin D level was not reported in this US study and confidence 
intervals of effect estimates overlapped widely, limiting any inference to effect modification 
by season. Nevertheless, overall vitamin D levels were comparatively high in this study and 
no difference in absolute vitamin D levels were found between seasons. Importantly, even 
between October to March, the number of months with adequate UVB exposition in this 
region is much higher than in Germany and Norway and may explain our different findings.  
Three other studies investigating the influence of season on the association between vitamin 
D status and depression have failed to find any associations. In a study using data from the 
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Health Survey for England 2005 (Stewart and Hirani, 2010), including 2,070 participants 
aged >=65 years, depressive symptoms (defined using a Geriatric Depression Scale (GDS10) 
score >=3) were associated with vitamin D levels <25 nmol/l in the overall sample but 
without effect modification by season (interaction term: p=0.84) in an analysis adjusted for 
age, sex and social class. Similar results were reported from the ‘Amsterdam Born Children 
and Their Development cohort’, which measured vitamin D status and depressive symptoms 
(defined as a score >=16 on the 20-item CES-D scale) in 4,101 pregnant women with mean 
age of 31 years (Brandenbarg et al., 2012). Analyses showed an inverse association between 
vitamin D concentrations and levels of depressive symptoms but no effect modification by 
season (interaction term: p=0.39). Similarly, although using different methods, a study of 527 
office workers in Japan aged 21 to 67 years (Nanri et al., 2009) found no significant 
association between vitamin D status and depressive symptoms (CES-D score of >= 16) or 
severe depressive symptoms (CES-D score of >= 23) between two groups of workers 
examined in different seasons (July and November). 
Conflicting results found across previous studies are likely to be underpinned by diverse study 
methodology. Several differences including the observed population and age groups, 
definitions of seasons, heterogenity in instruments used to assess depressive symptoms, and 
various methods to analyse vitamin D and cut-offs to determine depression and vitamin D 
deficiency make direct comparisons with previous studies challenging. Moreover, studies 
accounted for different confounders which is likely to contribute to these incongruent 
findings.  
Although many cross-sectional and longitudinal studies observed an inverse association 
between vitamin D and depressive symptoms, the direction of causation remains unclear. 
Regarding, for example, the effects of vitamin D on nerve growth factor synthesis or 
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neurotransmitter like serotonin, lower levels may contribute to depression (Brown et al., 
2003; Cass et al., 2006; Garcion et al., 2002; Smith et al., 2006; Wion et al., 1991). On the 
other hand, vitamin D deficiency may also be a consequence of depression. Depressed 
persons are more likely to stay inside and, thus, less exposed to sunlight. While this is less 
important during fall and winter because the endogenous vitamin D production is limited in 
northern latitudes (above latitude 35° North), and outside activity does not have an impact on 
vitamin D level, it is of more consequence in the summer half year when vitamin D synthesis 
is possible. Following this reasoning, the results of this study tend to support the hypothesis 
that vitamin D deficiency may be a consequence rather than a cause of depression, as the 
association is stronger during summer when vitamin D status is influenced mostly by 
individual behavior and exposure to UVB radiation during outdoor activities.  
However, the PHQ-9 may have a higher disciminative sensitivity in summertime given the 
generally higher levels of depressive symptoms and therefore smaller differences between 
25(OH)D quartiles in wintertime. As the current study was a crossectional design and 
therefore precluding any causal implications, longitudinal studies considering the amount of 
activities in UVB exposure might help clarify the role of season in the association of vitamin 
D and depressive symptoms.  
 
4.1 Limitations 
Participants with severe depression or other severe diseases are likely to be underrepresented 
in the DEGS1 study sample. Furthermore, data on depressive symptoms and some of the 
covariables are based on self-reports. Regarding the association between vitamin D and 
depressive symptoms and its wide range of confounding factors, residual or unknown 
confounding cannot be excluded. Some confounders we did not control for, either because we 
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have not measured them at all or not comprehensively e.g. social support. For some important 
unmeasured confounders, we tried to include proxies in statistical models e.g. physical 
functioning and participation in sports activities for the amount of time spend outdoors and 
sunlight exposure.  
Finally, although serum 25(OH)D is a commonly used biomarker of vitamin D status, there is 
no consensus in measurement due to a wide range of analytic methods, assays, and devices 
(Lips et al., 1999; Sempos et al., 2012). As reported in numerous studies, inter-assay 
differences can lead to dissimilar results for 25(OH)D (Binkley et al., 2004; Carter, 2012; 
Carter et al., 2004). The Liaison chemiluminescence immunoassay used in DEGS1, for 
example, tends to underestimate the concentration of 25(OH)D in the lower measurement 
range.  
 
5. Conclusion 
In conclusion, we found that current depressive symptoms defined by Patient Health 
Questionnaire (PHQ-9) were associated with vitamin D status in summer but not in 
wintertime in the adult population aged 18–79 years in Germany. The association in the 
summertime suggests that the relationship between vitamin D status and current depressive 
symptoms are greatest when UVB exposure opportunities are higher. These findings support 
the idea that vitamin D deficiency may be a consequence rather than a cause of depression. 
Longitudinal studies considering the amount of UVB exposure may help clarify the role of 
season in the association of vitamin D and depressive symptoms. 
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Table 1. Characteristics of the study population (n=6.331) according to serum 25(OH)D quartiles and 
prevalence of elevated depressive symptoms (PHQ-9 >=10) * 
 
Tota
l 
Serum 25(OH)D in nmol/l  
Elevated 
depressive 
symptoms  
(PHQ-9 ≥=10) 
 
 
% 
Q1 
(9-27) 
Q2 
(28-42) 
Q3 
(43-59) 
Q4 
(60-347) 
p-
value
1 
PHQ-9 
<10 
PHQ-
9 
>=10 
p-
value
1 
 
 
(n=1,51
2) 
(n=1,57
8) 
(n=1,56
9) 
(n=1,67
2) 
 
(n=5,89
2) 
(n=43
9) 
 
Female sex 
49.9 49.2 49.3 50.2 50.6 0.9 48.8 63.3 
<0.00
1 
Age group 
     
<0.00
1 
  0.07 
  18-29 
years 19.7 
19.8 17.7 16.6 24.3  19.2 25.6  
  30-39 
years 15.0 
16.7 14.0 12.6 16.3  14.9 15.6  
  40-49 
years 21.5 
21.8 20.6 22.4 21.3  21.5 21.8  
  50-59 
years 18.7 
18.6 20.6 19.9 16.2  18.8 17.8  
  60-69 
years 13.9 
10.7 14.4 16.9 13.9  14.1 11.8  
  70-79 
years 11.2 
12.4 12.7 11.8 8.1  11.5 7.3  
Summerti
me 
examinatio
n (May-
October) 
47.7 19.1 39.2 59.2 72.9 
<0.00
1 
47.5 50.2 0.4 
Socio-
economic 
status 
     
<0.00
1 
  
<0.00
1 
   Low 17.3 21.9 19.2 16.0 12.4  16.3 30.5  
   Middle 61.5 60.1 60.4 60.5 64.7  61.9 56.7  
   High 21.2 18.0 20.4 23.5 22.9  21.9 12.8  
Living in a 
partnership 
79.9 74.6 80.4 81.9 82.6 
<0.00
1 
80.6 71.4 
<0.00
1 
Municipali      0.6   0.001 
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ty size 
   <5.000 
residents 
15.8 14.9 16.2 17.0 15.3  16.1 12.7  
   5.000-
<20.000 
residents 
24.1 20.2 24.0 24.9 27.2  24.7 16.6  
   20.000-< 
100.000 
residents 
29.0 30.3 27.9 28.8 28.9  28.7 31.8  
   
>=100.000 
residents 
31.1 34.6 32.0 29.3 28.6  30.5 38.9  
Country of 
birth 
     
<0.00
1 
  0.005 
   Germany 87.7 85.0 89.0 87.4 89.2  88.3 79.7  
   Europe 
and 
Western 
countries                    
9.5 8.8 8.3 11.3 9.8  9.1 15.1  
   Arab-
Islamic 
countries 
2.1 5.2 1.6 0.7 0.8  1.9 4.3  
   
Remaining 
countries 
0.7 1.0 1.1 0.6 0.2  0.7 0.9  
Table 1 (continued). 
 Total Serum 25(OH)D in nmol/l  Depressive symptoms  
 
% 
Q1 
(9-27) 
Q2 
(28-42) 
Q3 
(43-59) 
Q4 
(60-347) 
p-value
1 
PHQ-9 
<10 
PHQ-9 
>=10 
p-value
1 
  (n=1,512) (n=1,578) (n=1,569) (n=1,672)  (n=5,892) (n=439)  
Obesity (Body Mass Index >=30kg/m2) 22.7 30.6 25.4 20.5 14.6 <0.001 21.8 33.6 <0.001 
  Mean  Mean  
Physical Functioning Scale (SF-36), 
mean score 
87.3 84.0 86.8 88.4 89.9 <0.001 88.3 74.7 <0.001 
Mean eGFR in mL/min/1.73 m2  95.3 97.6 93.7 93.4 96.5 <0.001 95.2 97.5 0.04 
No current smoking 70.5 67.3 70.8 75.7 68.5 0.001 71.2 61.8 0.001 
Alcohol consumption       <0.001   <0.001 
   no consumption 13.3 17.4 15.2 9.5 10.8  12.6 21.3  
   <20g/day men, <10 g/day women 70.8 65.9 71.2 74.8 71.7  71.8 58.7  
   >20g/day men, >10 g/day women 15.9 16.7 13.6 15.7 17.5  15.6 20.0  
Sport activity > 0 h/week 67.5 57.2 63.9 71.3 77.5 <0.001 68.5 55.4 <0.001 
* Results are weighted population estimates expressed as column percentage unless otherwise indicated; 
abbreviations: Q = quartile; 25(OH)D = 25-hydroxy-vitamin D; PHQ-9 = Patient Health Questionnaire 9 item 
depression module; SF-36 = 36-Item Short Form Survey; eGFR = estimated glomerular filtration rate 
1 P-values are based on chi 
2 test for categorical variables and on linear regression for numerical variables; p-values refer to differences 
between groups according to 25(OH)D or elevated depressive symptoms  in each sample characteristic
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Table 2. Severity of depressive symptoms (mean PHQ-9 - score) and prevalence of elevated 
depressive symptoms (PHQ-9 >=10) according to vitamin D quartiles, year-round and stratified by 
half year 
 
All figures are weighted population estimates.Abbreviations: Q = quartile; PHQ = Patient Health Questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Serum 25(OH)D in nmol/l  
 Q1 Q2 Q3 Q4 
p for 
trend 
PHQ-9 sum score, mean 
(95% CI) 
     
   Year-round 
4.47 (4.20-
4.75) 
3.96 (3.76-
4.16) 
3.94 (3.70-
4.17) 
3.90 (3.66-
4.14) 
0.002 
   Summer half year 
5.32 (4.75-
5.89) 
4.18 (3.82-
4.54) 
3.90 (3.58-
4.21) 
3.83 (3.55-
4.12) 
<0.001 
   Winter half year 
4.27 (3.97-
4.57) 
3.81 (3.58-
4.05) 
3.99 (3.64-
4.35) 
4.07 (3.61-
4.53) 
0.3 
PHQ-9>=10, % (95% 
CI) 
     
   Year-round 9.5 (7.6-
11.8) 
6.1 (4.8-7.8) 6.7 (5.2-8.6) 7.8 (6.1-9.8) 0.2 
   Summer half year 14.9 (10.4-
20.9) 
7.6 (5.3-
10.7) 
6.3 (4.4-9.0) 
7.5 (5.6-
10.0) 
0.03 
   Winter half year 8.3 (6.3-
10.8) 
5.2 (3.6-7.3) 
7.2 (5.0-
10.2) 
8.4 (5.5-
12.7) 
0.9 
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Table 3. Results of multivariable linear regression analyses examining associations between 25(OH)D 
quartiles and severity of depressive symptoms (PHQ-9 score) stratified by extended seasons 
(November-April; May-October)  
  
Wintertime (November-April; 
n=3,263) 
Summertime (May-October; n=3,068) 
  Beta 95 % CI 
p-
value 
Beta 95 % CI 
p-
value 
Model 1 Quartile 1 reference    reference    
 Quartile 2 -0.45 -0.81 -0.09 0.01 -1.03 -1.61 -0.44 <0.01 
 Quartile 3 -0.25 -0.70 0.20 0.26 -1.32 -1.98 -0.66 <0.01 
 Quartile 4 -0.32 -0.81 0.18 0.21 -1.46 -2.07 -0.86 <0.01 
 trend -0.11   0.17 -0.38   <0.01 
Model 2 Quartile 1 reference    reference    
 Quartile 2 -0.37 -0.73 -0.01 0.05 -0.87 -1.45 -0.29 <0.01 
 Quartile 3 -0.12 -0.58 0.34 0.61 -1.10 -1.73 -0.46 <0.01 
 Quartile 4 -0.15 -0.66 0.36 0.56 -1.20 -1.81 -0.58 <0.01 
 trend -0.05   0.55 -0.30   <0.01 
Model 3 Quartile 1 reference    reference    
 Quartile 2 -0.09 -0.42 0.25 0.61 -0.59 -1.19 0.02 0.06 
 Quartile 3 0.23 -0.17 0.63 0.25 -0.63 -1.23 -0.02 0.04 
 Quartile 4 0.20 -0.29 0.69 0.42 -0.72 -1.30 -0.14 0.02 
 trend 0.09   0.25 -0.17   0.05 
Model 4 Quartile 1 reference    reference    
 Quartile 2 -0.04 -0.38 0.29 0.80 -0.59 -1.19 0.02 0.06 
 Quartile 3 0.29 -0.12 0.70 0.17 -0.62 -1.23 -0.02 0.04 
 Quartile 4 0.22 -0.27 0.71 0.37 -0.73 -1.31 -0.14 0.02 
 trend 0.10   0.20 -0.17   0.04 
Abbreviations: 25(OH)D = 25-hydroxy-vitamin D; PHQ = Patient Health Questionnaire; CI = Confidence 
interval 
Model 1: adjusted for sex and age 
Model 2: Model 1 + adjusted for socio-economic status, partnership, municipality size and country of birth 
Model 3: Model 2 + adjusted for obesity, physical functioning and eGFR 
Model 4: Model 3 + adjusted for smoking status, alcohol consumption and sport activity 
 
 
 
Table 4. Results of multivariable logistic regression analyses examining associations between 
25(OH)D quartiles and elevated depressive symptoms (PHQ-9 >=10) stratified by extended season 
(November-April; May-October)  
  Winter (November-April; n=3,263) Summer (May-October; n=3,068) 
  OR 95 % CI 
p-
value 
OR 95 % CI p-value 
Model 1 Quartile 1 reference    reference    
 Quartile 2 0.59 0.36 0.96 0.03 0.50 0.29 0.86 0.01 
 Quartile 3 0.83 0.51 1.34 0.44 0.41 0.23 0.72 <0.01 
 Quartile 4 0.91 0.56 1.49 0.71 0.47 0.27 0.79 0.01 
 trend 0.96   0.59 0.82   0.03 
Model 2 Quartile 1 reference    reference    
 Quartile 2 0.65 0.39 1.09 0.10 0.53 0.30 0.93 0.03 
 Quartile 3 0.96 0.58 1.60 0.88 0.45 0.25 0.81 <0.01 
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 Quartile 4 1.10 0.67 1.79 0.71 0.55 0.32 0.97 0.04 
 trend 1.02   0.77 0.87   0.13 
Model 3 Quartile 1 reference    reference    
 Quartile 2 0.78 0.46 1.33 0.36 0.61 0.33 1.16 0.13 
 Quartile 3 1.29 0.76 2.20 0.34 0.62 0.34 1.15 0.13 
 Quartile 4 1.41 0.85 2.35 0.18 0.77 0.42 1.40 0.39 
 trend 1.14   0.13 0.97   0.71 
Model 4 Quartile 1 reference    reference    
 Quartile 2 0.83 0.49 1.40 0.48 0.61 0.32 1.16 0.13 
 Quartile 3 1.41 0.84 2.37 0.20 0.65 0.36 1.19 0.16 
 Quartile 4 1.50 0.91 2.47 0.11 0.79 0.44 1.44 0.44 
 trend 1.17   0.07 0.98   0.81 
Abbreviations: 25(OH)D = 25-hydroxy-vitamin D; PHQ = Patient Health Questionnaire; OR = Odds Ratio; CI = 
Confidence interval 
Model 1: adjusted for sex and age 
Model 2: Model 1 + adjusted for socio-economic status, partnership, municipality size and country of birth 
Model 3: Model 2 + adjusted for obesity, physical functioning and eGFR 
Model 4: Model 3 + adjusted for smoking status, alcohol consumption and sport activity 
 
 
Highlights 
 There are conflicting reports on the association between vitamin D and depression. 
 Vitamin D status is associated with depressive symptoms only in summer time. 
 Vitamin D deficiency may be a consequence rather than a cause of depression. 
 
 
